GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (MEX:IQV) » Definitions » Cyclically Adjusted Price-to-FCF

IQVIA Holdings (MEX:IQV) Cyclically Adjusted Price-to-FCF : 16.48 (As of Jun. 04, 2025)


View and export this data going back to 2018. Start your Free Trial

What is IQVIA Holdings Cyclically Adjusted Price-to-FCF?

As of today (2025-06-04), IQVIA Holdings's current share price is MXN2792.00. IQVIA Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was MXN169.42. IQVIA Holdings's Cyclically Adjusted Price-to-FCF for today is 16.48.

The historical rank and industry rank for IQVIA Holdings's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

MEX:IQV' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 17.43   Med: 34.44   Max: 59.79
Current: 18.15

During the past years, IQVIA Holdings's highest Cyclically Adjusted Price-to-FCF was 59.79. The lowest was 17.43. And the median was 34.44.

MEX:IQV's Cyclically Adjusted Price-to-FCF is ranked better than
65.15% of 66 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.485 vs MEX:IQV: 18.15

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

IQVIA Holdings's adjusted free cash flow per share data for the three months ended in Mar. 2025 was MXN49.127. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is MXN169.42 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


IQVIA Holdings Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for IQVIA Holdings's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IQVIA Holdings Cyclically Adjusted Price-to-FCF Chart

IQVIA Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 58.00 35.63 35.85 26.42

IQVIA Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.07 29.97 32.58 26.42 22.43

Competitive Comparison of IQVIA Holdings's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, IQVIA Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IQVIA Holdings's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's Cyclically Adjusted Price-to-FCF falls into.


;
;

IQVIA Holdings Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

IQVIA Holdings's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=2792.00/169.42
=16.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IQVIA Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, IQVIA Holdings's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=49.127/134.9266*134.9266
=49.127

Current CPI (Mar. 2025) = 134.9266.

IQVIA Holdings Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 4.373 100.684 5.860
201509 34.807 100.392 46.781
201512 25.892 99.792 35.008
201603 12.194 100.470 16.376
201606 1.522 101.688 2.019
201609 38.129 101.861 50.506
201612 31.617 101.863 41.880
201703 -1.763 102.862 -2.313
201706 11.790 103.349 15.392
201709 28.755 104.136 37.257
201712 12.011 104.011 15.581
201803 8.055 105.290 10.322
201806 18.816 106.317 23.879
201809 19.989 106.507 25.323
201812 26.854 105.998 34.183
201903 -2.693 107.251 -3.388
201906 22.599 108.070 28.215
201909 17.956 108.329 22.365
201912 42.720 108.420 53.164
202003 2.636 108.902 3.266
202006 39.901 108.767 49.497
202009 47.265 109.815 58.073
202012 58.464 109.897 71.780
202103 75.303 111.754 90.917
202106 40.241 114.631 47.366
202109 71.804 115.734 83.711
202112 53.442 117.630 61.301
202203 34.077 121.301 37.905
202206 17.686 125.017 19.088
202209 74.130 125.227 79.872
202212 40.233 125.222 43.351
202303 24.180 127.348 25.619
202306 22.222 128.729 23.292
202309 41.035 129.860 42.636
202312 52.257 129.419 54.481
202403 33.949 131.776 34.761
202406 44.235 132.554 45.027
202409 61.038 133.029 61.909
202412 83.215 133.157 84.321
202503 49.127 134.927 49.127

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


IQVIA Holdings  (MEX:IQV) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


IQVIA Holdings Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of IQVIA Holdings's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


IQVIA Holdings Business Description

Address
2400 Ellis Road, Durham, NC, USA, 27703
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.